2019-02-12

OssDsign AB raises 64 MSEK (6 MEUR) through private placement and initiates preparations for stock exchange listing

Uppsala, Sweden 2019-02-12 | OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for improved healing of bone defects, today announced the closing of a private placement of 64 MSEK (6 MEUR). The financing was achieved through a combination of Swedish private investors and the French investment management company Alto Invest. OssDsign will now also initiate the process towards a stock exchange listing during 2019.
2018-10-29

Retrospective study featuring OSSDSIGN® Cranial published in World Neurosurgery

Uppsala, Sweden 2018-10-29 | OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial reconstruction, today announced positive results from a retrospective study of OSSDSIGN® Cranial PSI that has been accepted for publication in World Neurosurgery.
2018-10-22

OssDsign announces FDA 510(k) clearance of OSSDSIGN® Cranioplug – designed with a ceramic material component that resorbs and is replaced with bone during the healing process

Uppsala, Sweden 2018-10-22 | OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial reconstruction, today announced that it has received 510(k) clearance by the US FDA for marketing and sale of its latest product, OSSDSIGN® Cranioplug.
2018-09-20

Major cranial reconstruction: Case report published in Journal of Neurosurgery

On September 14 th , the renowned Journal of Neurosurgery published a case report...
2018-07-05

OssDsign co-founder Håkan Engqvist receives Uppsala University Innovation Prize

Uppsala University's award for successful knowledge transfer, "hjärnäpplet", has...
2018-03-20

OssDsign nominated for AGS Innovation Award 2018

Uppsala 2018-03-20 | OssDsign has been nominated for the German AGS Innovation Award 2018. The award is a yearly initiative from the German SPD's entrepreneurial branch AGS.
2018-03-05

Patient story with OSSDSIGN Cranial featured in Minnesota newspaper

A patient story using OSSDSIGN Cranial PSI is currently featured in the Minnesota...
2018-01-22

OssDsign gains attention in local media

OssDsign gains local attention from Uppsala Nya Tidning (UNT) - click on this link...
2018-01-16

OssDsign accelerates commercial efforts in the US

Uppsala 2018-01-16 | OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced that it has established a US subsidiary and made initial key recruitments.
2017-09-27

Swedish research provides solution for untreatable patients

Uppsala 2017-09-27 | A patient with a large cranial tumor was successfully operated by neurosurgeons at Uppsala University Hospital in Sweden during the summer of 2017. During the surgery, the majority of the patient’s cranium was substituted with a personalized implant from OssDsign. The implant material is the result of research carried out at Uppsala University and Karolinska University Hospital.
2017-09-08

Discover a new approach to cranioplasty at CNS in Boston

OSSDSIGN Cranial on display at CNS Annual Meeting in Boston, October 7-11.
2017-05-12

OssDsign receives award for Innovation of the Year

Uppsala, Sweden 12 May 2017. We are proud to announce that OssDsign have been...
2017-04-19

BRINGING LIFE TO CRANIOPLASTY

OSSDSIGN Cranial on display at the AANS in Los Angeles, April 22-26.
2017-02-02

OssDsign announces agreement for distribution of OSSDSIGN Cranial in the USA with Matador Medical Inc.

Uppsala 2/2/2017. OssDsign AB has signed an agreement with Matador Medical Inc. to act as its master distributor in the US market.
2017-01-20

OssDsign announces FDA 510(k) clearance of OSSDSIGN® Cranial for sale in the USA

Uppsala, Sweden 20/1/2017. OssDsign AB, a Swedish designer, manufacturer and distributor...
2017-01-12

OssDsign announces new partnerships for commercialisation of its novel medical implants in Europe

Uppsala, Sweden 12 January 2017. OssDsign AB today announced it has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands.

2016-04-20

OssDsign appoints Simon Cartmell as Chairman of the Board

Strengthens organization ahead of the US Launch of its Novel Regenerative Facial and Cranial Implants in 2017
2016-03-03

Meet OssDsign

We are looking forward to meet you at the following events during 2016.
2016-01-27

OssDsign receives CE mark approval for Cranioplug

OssDsign AB today announced that the company has received CE mark approval for its bio-ceramic burr hole plug - Cranioplug.
2015-11-04

OssDsign raises SEK 93 million (EUR 9.6 million) for commercial expansion

OssDsign AB today announced that it has successfully raised SEK 93 million (EUR 9.6 million), in a new equity financing.
2014-12-04

CRANIOPLASTY TODAY, ISSUE 1

In the News:
WHAT’S THE PROBLEM? - NATIONAL REGISTRIES AIM TO IMPROVE CRANIOPLASTY
In Depth
THE EVOLUTION OF CRANIAL IMPLANT MATERIALS - FROM REPAIR TOWARDS REGENERATION
2014-10-20

OSSDSIGN’S CRANIOPLUG RECEIVES MARKETING APPROVAL IN THE US

STOCKHOLM - October 20, 2014. OssDsign AB today announced that its bioceramic burr hole plug - Cranioplug - has received 510(k) clearance by the US Food and Drug Administration (FDA). Karolinska Development has a 26 percent ownership in OssDsign.